Stratec SE
SBS
Rank in Stocks
#14221
Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE... Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE (previously known as STRATEC Biomedical AG until its name change in December 2018) specializes in the development and manufacturing of cutting-edge automation and instrumentation systems. The company caters to the in-vitro diagnostics and life sciences sectors, operating across Germany, the European Union, and globally. Its business is divided into three primary segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment focuses on designing and fabricating automated analytical systems, along with necessary spare parts and supplies, for customers in clinical diagnostics and biotechnology. The Diatron segment provides a suite of systems, components, disposables, and assays for lower-volume hematology and clinical chemistry applications. Finally, the Smart Consumables segment is dedicated to engineering and producing intelligent consumables for the diagnostics, life sciences, and medical technology industries.
Share Price
$27.72
Last synced: 2026-11-09
Market Cap
$336.96M
Change (1 day)
-0.54%
Change (1 year)
11.29%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Stratec SE (SBS)
Category
Healthcare
Operating Margin for Stratec SE (SBS)
Operating Margin as of November 2026 TTM: 2.65%
According to Stratec SE's latest financial reports, its current operating margin (TTM) is 2.65%. At the end of 2025 the company had an operating margin of 3.43%.
Operating Margin history for Stratec SE from 2002 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 2.65% | -22.74% |
| 2025 | 3.43% | -68.65% |
| 2024 | 10.94% | 5.19% |
| 2023 | 10.40% | -31.98% |
| 2022 | 15.29% | -11.46% |
| 2021 | 17.27% | 32.95% |
| 2020 | 12.99% | 58.22% |
| 2019 | 8.21% | 0.24% |
| 2018 | 8.19% | -40.44% |
| 2017 | 13.75% | 5.04% |
| 2016 | 13.09% | -28.47% |
| 2015 | 18.30% | 10.24% |
| 2014 | 16.60% | 9.00% |
| 2013 | 15.23% | 19.73% |
| 2012 | 12.72% | -28.86% |
| 2011 | 17.88% | 8.36% |
| 2010 | 16.50% | -8.69% |
| 2009 | 18.07% | 168.10% |
| 2008 | 6.74% | -85.53% |
| 2007 | 46.57% | 0.00% |
| 2006 | 0.00% | -100.00% |
| 2005 | 31.61% | 12.29% |
| 2004 | 28.15% | 8.35% |
| 2003 | 25.98% | -62.12% |
| 2002 | 68.59% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -94.25% |
US
|
|
| 18.08% | -93.18% |
IE
|
|
| 21.25% | -91.98% |
US
|
|
| 21.05% | -92.06% |
US
|
|
| 28.09% | -89.40% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Stratec SE's operating margin
What is Stratec SE's operating margin?
Stratec SE's operating margin is 2.65%, as of Nov 2026.
What was Stratec SE's operating margin in 2025?
In 2025, Stratec SE's operating margin was 3.43%, compared with 10.94% in 2024.
How has Stratec SE's operating margin changed since 2020?
From 2020 to 2025, Stratec SE's operating margin was highest in 2021 (17.27%) and lowest in 2025 (3.43%).
How does Stratec SE's operating margin compare with similar companies?
Stratec SE's operating margin (2.65%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.